Synlogic begins phase I study of SYNB-1891 in advanced/metastatic solid tumors and lymphoma Dec. 9, 2019
Preliminary data presented for TN-383B in patients with relapsed or refractory multiple myeloma Dec. 9, 2019
AAV2 capsid fitness landscape allows systematic optimization of natural capsids for gene therapy Dec. 9, 2019
Safety and efficacy of SST2 antagonist [177Lu]-satoreotide tetraxetan in advanced SST2+ NET Dec. 9, 2019
CC-90009 shows antileukemic activity in patients with relapsed/refractory acute myeloid leukemia Dec. 9, 2019
RSS